Mebhydrolin

Mebhydrolin is a sedative anti-histamine with anti-muscarinic properties. Mebhydrolin is used for the symptomatic relief of allergic conditions including urticaria, rhinitis and, in pruritic skin disorders.

Mebhydrolin is primarily indicated in conditions like Allergy, Angioedema, Eczema, Hay fever, Pruritus, Rhinitis, Urticaria.

Mebhydrolin is contraindicated in conditions like Prostatic hypertrophy, Narrow-angle glaucoma, Hypersensitivity to any component of product.

The severe or irreversible adverse effects of Mebhydrolin, which give rise to further complications include Granulocytopenia, Neutropenia, Agranulocytosis. Mebhydrolin produces potentially life-threatening effects which include Blood dyscrasias. which are responsible for the discontinuation of Mebhydrolin therapy. The symptomatic adverse reactions produced by Mebhydrolin are more or less tolerable and if they become severe, they can be treated symptomatically, these include Sleepiness, Drowsiness.

Patients should observed caution while driving or performing other tasks requiring alertness, because may cause drowsiness. Mebhydrolin should be used with caution in patients with liver impairment, dose should be reduced in patients with renal impairment.

Drug should not be given to Pregnant Mothers. If prescribing authority justifies the benefits of the drug against the possible damages he/she should reevaluate them and consult the reference material and previous studies.

50 to 100 mg (75 (75)) 8 hourly PO —

5 mg/kg (5 (5)) 8 hourly Oral — -

6.25 mg/kg (6.2 (6.25)) 12 hourly Oral —

No data regarding the interactions of Mebhydrolin was found.

No storage information is recorded for this medicine yet.